Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. futures hold steady amid Fed speculation; Dow Jones down 0.04%

Published 06/26/2014, 06:42 AM
Updated 06/26/2014, 06:42 AM
U.S. futures point to steady open after Wednesday rally

Investing.com - U.S. stock futures pointed to a steady open on Thursday, after Wednesday's rally in U.S. equities as weak U.S. data fuelled expectations that the Federal Reserve will keep rates hold for longer.

Ahead of the open, the Dow 30 futures pointed to a 0.04% dip, S&P 500 futures signaled a 0.09% loss, while the Nasdaq 100 futures indicated a 0.01% downtick.

The Commerce Department on Wednesday said U.S. gross domestic product contracted at an annual rate of 2.9% in the first three months of the year, compared to the consensus forecast for a decline of 1.7%.

U.S. first quarter GDP was initially reported to have increased by 0.1%, but was subsequently revised to show a contraction of 1.0%.

The difference between the second and third estimate was the largest since records began in 1976, the Commerce Department said.

General Motors (NYSE:GM) was expected to be active, as shares dropped 0.51% in extended trade following reports the automaker may need to fix its top-selling Chevrolet Cruze for a new type of air-bag problem.

The news came as the company has already recalled a record number of vehicles in the U.S. this year due to defaults linked to at least 13 deaths.

Philip Morris International (NYSE:PM) also slipped 0.10% after hours, as the tobacco company lowered its annual earnings projection.

CBS (NYSE:CBS) edged down 0.13% in late trading, after rallying over 6% on Wednesday when the Supreme Court ruled in favor of the network and three others, including NBC, CNBC's parent, saying TV startup Aereo had violated copyright law.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Elsewhere, Bristol-Myers Squibb (NYSE:BMY) shares rose 0.20% in extended trade after halting a late-stage trial of an experimental skin cancer drug after patients showed "superior overall survival."

Other stocks likely to be in focus included Winnebago (NYSE:WGO), Accenture (NYSE:ACN), ConAgra Foods (NYSE:CAG) and Nike (NYSE:NKE), scheduled to release quarterly earnings later in the day.

Across the Atlantic, European stock markets were mostly lower. The DJ Euro Stoxx 50 slipped 0.18%, France’s CAC 40 dipped 0.01%, Germany's DAX eased 0.05%, while Britain's FTSE 100 edged 0.07% lower.

During the Asian trading session, Hong Kong's Hang Seng jumped 1.45%, while Japan’s Nikkei 225 rose 0.27%.

Later in the day, the U.S. was to release data on personal income and expenditure, as well as data on inflation linked to personal spending.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.